Although siRNAs have surpassed expectations in experiments to alter gene expression in vitro, the lack of an efficient in vivo delivery system still remains a challenge in siRNA therapeutics development and has been recognized as a major hurdle for clinical applications. in this paper we describe an inorganic nanoparticle-based delivery system that is readily adaptable for in vivo systems. Layered double hydroxide (LDH) nanoparticles, a family of inorganic crystals, tightly bind, protect, and release siRNA molecules and deliver them efficiently to mammalian cells in vitro. The uptake of siRNA-loaded LDH nanoparticles occurs via endocytosis, whereby the nanoparticles dissolve due to the low pH in the endosome, thereby aiding endosomal escape...
Suitable carriers are crucial to RNAi applications for cancer genotherapy and T-cell immunotherapy. ...
Layered double hydroxide (LDH) nanoparticles (NPs) are safe and effective vectors for small interfer...
Suitable carriers are crucial to RNAi applications for cancer genotherapy and T-cell immunotherapy. ...
Small interfering RNAs (siRNAs) are capable of targeting and destroying specific mRNAs, making them ...
In this paper, we report the novel finding that the cellular delivery efficiency of siRNAs or their ...
Layered double hydroxides (LDHs) have been known for many decades as catalyst and ceramic precursors...
This paper briefly reviews the recent progress in using layered double hydroxide (LDH) nanomaterials...
Gene and drug delivery systems need crucial update in the issue of nanocarriers. Layered double hydr...
We prepared stable homogeneous suspensions with layered double hydroxide (LDH) nanoparticles for in ...
Current investigations show that layered double hydroxide (LDH) nanoparticles have high potential as...
Nonviral vectors offer a safe alternative to viral vectors for gene therapy applications, albeit typ...
Layered Double Hydroxides (LDHs)-based drug delivery systems have, for many years, shown great promi...
Layered Double Hydroxides (LDHs)-based drug delivery systems have, for many years, shown great promi...
Sheet-like layered double hydroxide nanoparticles (LDH NPs) have showed great potentials in biomedic...
Layered double hydroxides (LDHs) have been known for many decades as catalyst and ceramic precursors...
Suitable carriers are crucial to RNAi applications for cancer genotherapy and T-cell immunotherapy. ...
Layered double hydroxide (LDH) nanoparticles (NPs) are safe and effective vectors for small interfer...
Suitable carriers are crucial to RNAi applications for cancer genotherapy and T-cell immunotherapy. ...
Small interfering RNAs (siRNAs) are capable of targeting and destroying specific mRNAs, making them ...
In this paper, we report the novel finding that the cellular delivery efficiency of siRNAs or their ...
Layered double hydroxides (LDHs) have been known for many decades as catalyst and ceramic precursors...
This paper briefly reviews the recent progress in using layered double hydroxide (LDH) nanomaterials...
Gene and drug delivery systems need crucial update in the issue of nanocarriers. Layered double hydr...
We prepared stable homogeneous suspensions with layered double hydroxide (LDH) nanoparticles for in ...
Current investigations show that layered double hydroxide (LDH) nanoparticles have high potential as...
Nonviral vectors offer a safe alternative to viral vectors for gene therapy applications, albeit typ...
Layered Double Hydroxides (LDHs)-based drug delivery systems have, for many years, shown great promi...
Layered Double Hydroxides (LDHs)-based drug delivery systems have, for many years, shown great promi...
Sheet-like layered double hydroxide nanoparticles (LDH NPs) have showed great potentials in biomedic...
Layered double hydroxides (LDHs) have been known for many decades as catalyst and ceramic precursors...
Suitable carriers are crucial to RNAi applications for cancer genotherapy and T-cell immunotherapy. ...
Layered double hydroxide (LDH) nanoparticles (NPs) are safe and effective vectors for small interfer...
Suitable carriers are crucial to RNAi applications for cancer genotherapy and T-cell immunotherapy. ...